MATRICELF

Matricelf is a pioneering biotechnology company that develops a platform for autologous tissue engineering, for a wide range of medical conditions. The company was established in 2019 by Professor Tal Dvir from the Laboratory of tissue engineering and regenerative medicine from Tel Aviv University... Our technology enables the production of a complete autologous engineered tissue composed of extracellular matrix and cells derived from patients' own tissues. The matrix is a thermo-responsive hydrogel, prepared by decellularization of patient's omentum sample, while the cells are re-programmed from patient's mature cells to form induced Pluripotent Stem Cells (iPSCs). Ex-vivo differentiation of iPSCs within the thermo-responsive hydrogel leads to the generation of a functional mature tissue... Regenerating the Future of Medicine - Personalized platform for autologous regenerative medicine

Primary location: Ness Ziona Israel